Reporter Aug 12 2016

Using an antibody generated at Vanderbilt University Medical Center that neutralizes the Ebola virus, researchers at the Scripps Research Institute in La Jolla, California, have determined the structure of a “decoy” protein that may enable the virus to evade detection by the immune system.

With the theme of “It’s About People,” Jeff Balser M.D., Ph.D., President and CEO of Vanderbilt University Medical Center and Dean of Vanderbilt University School of Medicine, began the Summer Clinical Enterprise Leadership Assembly by urging nearly 1,000 Medical Center leaders in attendance in Langford Auditorium to consider the emotional needs of members of their teams. In particular, he asked leaders to recognize the psychological impact of recent tragic events happening across the U.S. and in other nations.

Antwane Cole Jr., known as “AJ” to friends and family, began his summer playing football and enjoying his favorite superhero, Spiderman.

Vanderbilt researchers have discovered a novel model of evolution for factors that control gene expression.

Hypoxia (lack of enough oxygen) is bad for the body as a whole, but in the neighborhood where infection-fighting antibodies arise, may be important for keeping proper order.

More people needing neurology care can be admitted to Vanderbilt University Hospital after a team of employees eliminated delays in the discharge process to make beds available sooner.

Terunaga Nakagawa, with colleagues from Japan and Oxford University in England, has discovered the bridgelike molecular structure of a mysterious glutamate receptor.